STOCK TITAN

Point72, Steven A. Cohen Report 4.0% Ownership in ALT5 Sigma Corp

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Point72 reports a 4.0% common-stock holding in ALT5 Sigma Corp. The filing lists Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen as joint filers reporting shared voting and dispositive power over 4,872,756 shares as of the close of business on August 15, 2025. The filers state they directly own no shares and that the shares are held by an investment fund managed by Point72 Asset Management. The filing includes a joint filing agreement and a certification that the stake was not acquired to influence control.

Positive

  • Transparency: Public disclosure of a 4.0% stake by a major institutional manager enhances market transparency
  • Joint filing: Inclusion of a joint filing agreement clarifies coordination among reporting entities and beneficial ownership attribution

Negative

  • None.

Insights

TL;DR: Point72 discloses a modest 4.0% position in ALT5 Sigma, a non-controlling stake held via managed funds.

The Schedule 13G shows shared voting and dispositive power for 4,872,756 shares representing 4.0% of ALT5 Sigma's outstanding common stock as of August 15, 2025. Because the filing is on Schedule 13G and includes a certification that the position was not acquired to influence control, this is a passive disclosure rather than an activist or control-seeking move. For investors, the disclosure improves transparency about a notable institutional holder but does not signal an imminent governance change.

TL;DR: Joint filing by Point72 entities and Steven A. Cohen indicates coordinated reporting, not control intent.

The filing identifies Point72 Asset Management, Point72 Capital Advisors, Inc. and Steven A. Cohen as reporting persons and references a joint filing agreement. All report 0 sole voting/dispositive power and 4,872,756 shared voting/dispositive power, consistent with fiduciary management of a fund. The certification asserts no intent to influence control. From a governance perspective, this is routine disclosure of a significant institutional holding without immediate governance implications.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/18/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/18/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/18/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

What stake in ALT5 Sigma (CUSIP 74347B813) did Point72 report?

Point72 reported shared voting and dispositive power over 4,872,756 shares, representing 4.0% of ALT5 Sigma's common stock as of August 15, 2025.

Who filed the Schedule 13G for ALT5 Sigma?

The filing was made jointly by Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen with a Joint Filing Agreement attached as Exhibit 99.1.

Does the filing indicate Point72 intends to influence control of ALT5 Sigma?

No. The filing includes a certification stating the securities were not acquired to change or influence control and were not acquired in connection with any transaction having that purpose.

Do the reporting persons directly own the shares disclosed?

No. The filers state they directly own no shares; the shares are held by an investment fund managed by Point72 Asset Management.

What date is the ownership information current to?

The ownership figures are reported as of the close of business on August 15, 2025.
JanOne Inc.

NASDAQ:JAN

JAN Rankings

JAN Latest News

JAN Latest SEC Filings

JAN Stock Data

27.14M
12.17M
Household Appliance Stores
Pharmaceutical Preparations
Link
US
LAS VEGAS